Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis

Clinical and Vaccine Immunology

Volumn 14, Issue 11, 2007, Pages 1437-1441

  Hsieh, Yu Fan ^a   Liu, Han Wen ^a   Hsu, Tsai Ching ^a   Wei, James C C ^a   Shih, Chien Ming ^b   Krause, Peter J ^c   Tsay, Gregory J ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER SURFACE PROTEIN A;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNOREACTIVITY; LYME DISEASE; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BLOTTING, WESTERN; BORRELIA BURGDORFERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEINS; LYME DISEASE; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS;

EID: 37349026158     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00151-07     Document Type: Article

References (36)

1. Akin, E., G. L. McHugh, R. A. Flavell, E. Fikrig, and A. C. Steere. 1999. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67:173-181.
2. Alaedini, A., and N. Latov. 2005. Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue. J. Neuroimmunol. 159:192-195.
3. Arnett, F. C. 1987. Seronegative spondylarthropathies. Bull. Rheum. Dis. 37:1-12.
4. Barbour, A. G., R. A. Heiland, and T. R. Howe. 1985. Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J. Infect. Dis. 152:478-484.
5. Boers, M., P. Tugwell, D. T. Felson, P. L. van Riel, J. R. Kirwan, J. P. Edmonds, J. S. Smolen, N. Khaltaev, and K. D. Muirden. 1994. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J. Rheumatol. Suppl. 41:86-89.
6. Carlson, D., J. Hernandez, B. J. Bloom, J. Coburn, J. M. Aversa, and A. C. Steere. 1999. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 42:2705-2709.
7. Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance. Morb. Mortal. Wkly. Rep. Recomm. Rep. 46:1-55.
8. Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb. Mortal. Wkly. Rep. 44:590-591.
9. Chao, L. L., and C. M. Shih. 2002. Molecular characterization of Lyme disease spirochetes (Borrelia burgdorferi sensu lato) isolated in Taiwan by restriction fragment length polymorphism analysis of 5S(rrf)-23S(rrl) intergenic spacer amplicons. Am. J. Trop. Med. Hyg. 67:504-510.
10. Chary-Valckenaere, I., F. Guillemin, J. Pourel, F. Schiele, R. Heller, and B. Jaulhac. 1997. Seroreactivity to Borrelia burgdorferi antigens in early rheumatoid arthritis: a case-control study. Br. J. Rheumatol. 36:945-949.
11. Engstrom, S. M., E. Shoop, and R. C. Johnson. 1995. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33:419-427.
12. Fransen, J., M. C. Creemers, and P. L. Van Riel. 2004. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 43:1252-1255.
13. Ghosh, S., R. Seward, C. E. Costello, B. D. Stollar, and B. T. Huber. 2006. Autoantibodies from synovial lesions in chronic, antibiotic treatment-resistant Lyme arthritis bind cytokeratin-10. J. Immunol. 177:2486-2494.
14. Gross, D. M., T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z. A. Nagy, J. A. Field, A. C. Steere, and B. T. Huber. 1998. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281:703-706.
15. Hsu, T. C., C. H. Chang, M. C. Lin, S. T. Liu, T. J. Yen, and G. J. Tsay. 2006. Anti-CENP-H antibodies in patients with Sjogren's syndrome. Rheumatol. Int. 26:298-303.
16. Kalish, R. A., J. M. Leong, and A. C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61:2774-2779.
17. Kalish, R. A., J. M. Leong, and A. C. Steere. 1995. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 63:2228-2235.
18. Krause, P. J., D. T. Foley, G. S. Burke, D. Christiansen, L. Closter, and A. Spielman. 2006. Reinfection and relapse in early Lyme disease. Am. J. Trop. Med. Hyg. 75:1090-1094.
19. Magnarelli, L. A., E. Fikrig, S. J. Padula, J. F. Anderson, and R. A. Flavell. 1996. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis. J. Clin. Microbiol. 34:237-240.
20. Nocton, J. J., F. Dressler, B. J. Rutledge, P. N. Rys, D. H. Persing, and A. C. Steere. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330:229-234.
21. Pal, U., A. M. de Silva, R. R. Montgomery, D. Fish, J. Anguita, J. F. Anderson, Y. Lobet, and E. Fikrig. 2000. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. I. Clin. Investig. 106:561-569.
22. Pal, U., X. Li, T. Wang, R. R. Montgomery, N. Ramamoorthi, A. M. Desilva, F. Bao, X. Yang, M. Pypaert, D. Pradhan, F. S. Kantor, S. Telford, J. F. Anderson, and E. Fikrig. 2004. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 119:457-468.
23. Schoen, R. T., F. Meurice, C. M. Brunet, S. Cretella, D. S. Krause, J. E. Craft, and E. Fikrig. 1995. Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease. J. Infect. Dis. 172:1324-1329.
24. Schwan, T. G., and J. Piesman. 2000. Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J. Clin. Microbiol. 38:382-388.
25. Shih, C. M., and L. L. Chao. 2002. An OspA-based genospecies identification of Lyme disease spirochetes (Borrelia burgdorferi) isolated in Taiwan. Am. J. Trop. Med. Hyg. 66:611-615.
26. Shih, C. M., J. C. Wang, L. L. Chao, and T. N. Wu. 1998. Lyme disease in Taiwan: first human patient with characteristic erythema chronicum migrans skin lesion. J. Clin. Microbiol. 36:807-808.
27. Sigal, L. H. 1997. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu. Rev. Immunol. 15:63-92.
28. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
29. Steere, A. C., P. H. Duray, and E. C. Butcher. 1988. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 31:487-495.
30. Steere, A. C., B. Falk, E. E. Drouin, L. A. Baxter-Lowe, J. Hammer, and G. T. Nepom. 2003. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 48:534-540.
31. Steere, A. C., R. T. Schoen, and E. Taylor. 1987. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107:725-731.
32. Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, D. S. Krause, et al. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med. 339:209-215.
33. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271-1277.
34. van der Linden, S., H. A. Valkenburg, and A. Cats. 1984. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27:361-368.
35. Vitali, C., S. Bombardieri, R. Jonsson, H. M. Moutsopoulos, E. L. Alexander, S. E. Carsons, T. E. Daniels, P. C. Fox, R. I. Fox, S. S. Kassan, S. R. Pillemer, N. Talal, and M. H. Weisman. 2002. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum Dis. 61:554-558.
36. Weiss, N. L., V. A. Sadock, L. H. Sigal, M. Phillips, P. F. Merryman, and S. B. Abramson. 1995. False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis. Lupus 4:131-137.